United Therapeutics Investor
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products.
Technology:
COVID-19 Investors, Cell_Therapies
Industry:
Altered Signaling
Headquarters:
Silver Spring, Maryland, United States
Founded Date:
1996-01-01
Employees Number:
501-1000
Funding Status:
IPO
Investor Type:
N/A
Investment Stage:
N/A
Number Of Exits:
1
Estimated Revenue:
$100M to $500M
Register and Claim Ownership